Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Tarsus Pharmaceuticals, Inc. | exhibit3211.htm |
| EX-31.2 - EX-31.2 - Tarsus Pharmaceuticals, Inc. | exhibit3121.htm |
| EX-31.1 - EX-31.1 - Tarsus Pharmaceuticals, Inc. | exhibit3111.htm |
| EX-10.1 - EX-10.1 - Tarsus Pharmaceuticals, Inc. | exhibit101lian-tarsusxdeve.htm |
| 10-Q - 10-Q - Tarsus Pharmaceuticals, Inc. | tars-20210331.htm |
Exhibit 32.2
CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Tarsus Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Leo M. Greenstein, hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and | |||||||||||||||||||||||||
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. | |||||||||||||||||||||||||
Date: May 11, 2021 | By: | /s/ Leo M. Greenstein | |||||||||||||||||||||
Leo M. Greenstein | |||||||||||||||||||||||
Chief Financial Officer | |||||||||||||||||||||||
(Principal Financial Officer and Principal Accounting Officer) | |||||||||||||||||||||||